Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 1,057.71 | -19.17 |
PEG Ratio (TTM) | 10.58 | -5.61 |
P/S Ratio (TTM) | N/A | 41.30 |
P/B Ratio (TTM) | 0.82 | 5.67 |
P/FCF Ratio (TTM) | -427.93 | -148.36 |
Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.08% | 291.32% |
ROE (TTM) | 0.08% | -4,280.27% |
Net Profit Margin (TTM) | N/A | -1,106.71% |
ROIC 5YR AVG | N/A | -16.06% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -376.31% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -351.95% | N/A | N/A |
Cash Flow | -78.38% | N/A | N/A |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.59 | 4.95 |
Quick Ratio (TTM) | 1.59 | 4.93 |
D/E Ratio (TTM) | N/A | 1.29 |
Interest Coverage (TTM) | N/A | -11.14 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 19.64 | 21.20 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.86% |